To YH - Search Results

1

A tailored approach to horizon scanning for cancer medicines.

Soon JA, To YH, Alexander M, Trapani K, Ascierto PA, Athan S, Brown MP, Burge M, Haydon A, Hughes B, Itchins M, John T, Kao S, Koopman M, Li BT, Long GV, Loree JM, Markman B, Meniawy TM, Menzies AM, Nott L, Pavlakis N, Petrella TM, Popat S, Tie J, Xu W, Yip D, Zalcberg J, Solomon BJ, Gibbs P, McArthur GA, Franchini F, IJzerman M. Soon JA, et al. Among authors: to yh. J Cancer Policy. 2023 Dec;38:100441. doi: 10.1016/j.jcpo.2023.100441. Epub 2023 Nov 20. J Cancer Policy. 2023. PMID: 38008488 Free PMC article.

2

Circulating tumour DNA in early stage colorectal cancer: can blood tell all?

To YH, Lee M, Gibbs P, Tie J. To YH, et al. Ann Transl Med. 2019 Dec;7(Suppl 8):S358. doi: 10.21037/atm.2019.09.55. Ann Transl Med. 2019. PMID: 32016076 Free PMC article. No abstract available.

3

Circulating Tumour DNA to Guide Treatment of Gastrointestinal Malignancies.

To YH, Lee B, Wong HL, Gibbs P, Tie J. To YH, et al. Visc Med. 2020 Oct;36(5):388-396. doi: 10.1159/000509657. Epub 2020 Sep 18. Visc Med. 2020. PMID: 33178736 Free PMC article. Review.

4

Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting.

Kostos L, Hong W, Lee B, Tran B, Lok SW, Anton A, Gard G, To YH, Wong V, Shapiro J, Wong R, Wong S, de Boer R, Gibbs P. Kostos L, et al. Among authors: to yh. Int J Cancer. 2021 Jul 15;149(2):409-419. doi: 10.1002/ijc.33568. Epub 2021 Apr 13. Int J Cancer. 2021. PMID: 33729581

5

Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer.

To YH, Degeling K, Kosmider S, Wong R, Lee M, Dunn C, Gard G, Jalali A, Wong V, IJzerman M, Gibbs P, Tie J. To YH, et al. Pharmacoeconomics. 2021 Aug;39(8):953-964. doi: 10.1007/s40273-021-01047-0. Epub 2021 Jun 5. Pharmacoeconomics. 2021. PMID: 34089503

6

Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospitals.

To YH, Shapiro J, Wong R, Thomson B, Nagrial A, Mendis S, Gibbs P, Shapiro J, Lee B. To YH, et al. Asia Pac J Clin Oncol. 2022 Aug;18(4):448-455. doi: 10.1111/ajco.13721. Epub 2021 Nov 23. Asia Pac J Clin Oncol. 2022. PMID: 34811944

7

Biomarkers in Locally Advanced Rectal Cancer: A Review.

Mendis S, To YH, Tie J. Mendis S, et al. Among authors: to yh. Clin Colorectal Cancer. 2022 Mar;21(1):36-44. doi: 10.1016/j.clcc.2021.11.002. Epub 2021 Nov 20. Clin Colorectal Cancer. 2022. PMID: 34961731 Review.

8

Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal Cancer.

Mendis S, Hong W, Ananda S, Faragher I, Jones I, Croxford M, Steel M, Jalali A, Gard G, To YH, Lee M, Kosmider S, Wong R, Tie J, Gibbs P. Mendis S, et al. Among authors: to yh. JNCI Cancer Spectr. 2022 Jan 5;6(1):pkab100. doi: 10.1093/jncics/pkab100. JNCI Cancer Spectr. 2022. PMID: 35699496 Free PMC article.

9

Real-world adjuvant chemotherapy treatment patterns and outcomes over time for resected stage II and III colorectal cancer.

To YH, Degeling K, McCoy M, Wong R, Jones I, Dunn C, Hong W, Loft M, Gibbs P, Tie J. To YH, et al. Asia Pac J Clin Oncol. 2023 Jun;19(3):392-402. doi: 10.1111/ajco.13885. Epub 2022 Dec 4. Asia Pac J Clin Oncol. 2023. PMID: 36464923

10

Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review.

To YH, Gibbs P, Tie J, IJzerman M, Degeling K. To YH, et al. Cost Eff Resour Alloc. 2023 Jan 31;21(1):11. doi: 10.1186/s12962-023-00422-2. Cost Eff Resour Alloc. 2023. PMID: 36721219 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters